MicroRNAs as Targets for Lung Cancer

miRNA therapeutics face numerous challenges including targeted delivery, specificity, stability, immune response, and toxicity. Overcoming these challenges is paramount for success.

Written by
Elizabeth Bolitho
  • Categories
  • Target Selection
Receive the latest newsletter directly to your inbox

The Promise of MicroRNAs

Challenges of miRNA Therapeutics

miRNAs as Targets for NSCLC

MicroRNAs as Targets for Lung Cancer image 0
Figure 1. Dendrogram view of microRNAs with reported downregulated relationships with NSCLC.

MiR-144 as a miRNA Target


    More on Target Selection